Zealand Pharma A/S (ZLDPY)
OTCMKTS · Delayed Price · Currency is USD
14.27
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Zealand Pharma Revenue
Zealand Pharma had revenue of 49.57M DKK in the quarter ending September 30, 2025, with 1,022.74% growth. This brings the company's revenue in the last twelve months to 9.16B, up 11,809.72% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
9.16B DKK
Revenue Growth
+11,809.72%
P/S Ratio
3.14
Revenue / Employee
20.81M DKK
Employees
440
Market Cap
4.51B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
| Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
| Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
| Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
| Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GMéxico Transportes | 3.59B |
| Light & Wonder | 3.22B |
| First National of Nebraska | 1.89B |
| Starwood Real Estate Income Trust | 1.59B |
| Wilson Bank Holding Company | 207.51M |
| IPE Universal | 17.33M |
| Fast Finance Pay | 10.35M |
| Jingbo Technology | 1.85M |